Cargando…

Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model

BACKGROUND: Cost-effectiveness models require quality of life utilities calculated from generic preference-based questionnaires, such as EQ-5D. We evaluated the performance of available algorithms for QLQ-C30 conversion into EQ-5D-3L based utilities in a metastatic colorectal cancer (mCRC) patient p...

Descripción completa

Detalles Bibliográficos
Autores principales: Franken, Mira D., de Hond, Anne, Degeling, Koen, Punt, Cornelis J. A., Koopman, Miriam, Uyl-de Groot, Carin A., Versteegh, Matthijs M., van Oijen, Martijn G. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370458/
https://www.ncbi.nlm.nih.gov/pubmed/32690011
http://dx.doi.org/10.1186/s12955-020-01481-2
_version_ 1783560981280980992
author Franken, Mira D.
de Hond, Anne
Degeling, Koen
Punt, Cornelis J. A.
Koopman, Miriam
Uyl-de Groot, Carin A.
Versteegh, Matthijs M.
van Oijen, Martijn G. H.
author_facet Franken, Mira D.
de Hond, Anne
Degeling, Koen
Punt, Cornelis J. A.
Koopman, Miriam
Uyl-de Groot, Carin A.
Versteegh, Matthijs M.
van Oijen, Martijn G. H.
author_sort Franken, Mira D.
collection PubMed
description BACKGROUND: Cost-effectiveness models require quality of life utilities calculated from generic preference-based questionnaires, such as EQ-5D. We evaluated the performance of available algorithms for QLQ-C30 conversion into EQ-5D-3L based utilities in a metastatic colorectal cancer (mCRC) patient population and subsequently developed a mCRC specific algorithm. Influence of mapping on cost-effectiveness was evaluated. METHODS: Three available algorithms were compared with observed utilities from the CAIRO3 study. Six models were developed using 5-fold cross-validation: predicting EQ-5D-3L tariffs from QLQ-C30 functional scale scores, continuous QLQ-C30 scores or dummy levels with a random effects model (RE), a most likely probability method on EQ-5D-3L functional scale scores, a beta regression model on QLQ-C30 functional scale scores and a separate equations subgroup approach on QLQ-C30 functional scale scores. Performance was assessed, and algorithms were tested on incomplete QLQ-C30 questionnaires. Influence of utility mapping on incremental cost/QALY gained (ICER) was evaluated in an existing Dutch mCRC cost-effectiveness model. RESULTS: The available algorithms yielded mean utilities of 1: 0.87 ± sd:0.14,2: 0.81 ± 0.15 (both Dutch tariff) and 3: 0.81 ± sd:0.19. Algorithm 1 and 3 were significantly different from the mean observed utility (0.83 ± 0.17 with Dutch tariff, 0.80 ± 0.20 with U.K. tariff). All new models yielded predicted utilities drawing close to observed utilities; differences were not statistically significant. The existing algorithms resulted in an ICER difference of €10,140 less and €1765 more compared to the observed EQ-5D-3L based ICER (€168,048). The preferred newly developed algorithm was €5094 higher than the observed EQ-5D-3L based ICER. Disparity was explained by minimal diffences in incremental QALYs between models. CONCLUSION: Available mapping algorithms sufficiently accurately predict utilities. With the commonly used statistical methods, we did not succeed in developping an improved mapping algorithm. Importantly, cost-effectiveness outcomes in this study were comparable to the original model outcomes between different mapping algorithms. Therefore, mapping can be an adequate solution for cost-effectiveness studies using either a previously designed and validated algorithm or an algorithm developed in this study.
format Online
Article
Text
id pubmed-7370458
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73704582020-07-21 Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model Franken, Mira D. de Hond, Anne Degeling, Koen Punt, Cornelis J. A. Koopman, Miriam Uyl-de Groot, Carin A. Versteegh, Matthijs M. van Oijen, Martijn G. H. Health Qual Life Outcomes Research BACKGROUND: Cost-effectiveness models require quality of life utilities calculated from generic preference-based questionnaires, such as EQ-5D. We evaluated the performance of available algorithms for QLQ-C30 conversion into EQ-5D-3L based utilities in a metastatic colorectal cancer (mCRC) patient population and subsequently developed a mCRC specific algorithm. Influence of mapping on cost-effectiveness was evaluated. METHODS: Three available algorithms were compared with observed utilities from the CAIRO3 study. Six models were developed using 5-fold cross-validation: predicting EQ-5D-3L tariffs from QLQ-C30 functional scale scores, continuous QLQ-C30 scores or dummy levels with a random effects model (RE), a most likely probability method on EQ-5D-3L functional scale scores, a beta regression model on QLQ-C30 functional scale scores and a separate equations subgroup approach on QLQ-C30 functional scale scores. Performance was assessed, and algorithms were tested on incomplete QLQ-C30 questionnaires. Influence of utility mapping on incremental cost/QALY gained (ICER) was evaluated in an existing Dutch mCRC cost-effectiveness model. RESULTS: The available algorithms yielded mean utilities of 1: 0.87 ± sd:0.14,2: 0.81 ± 0.15 (both Dutch tariff) and 3: 0.81 ± sd:0.19. Algorithm 1 and 3 were significantly different from the mean observed utility (0.83 ± 0.17 with Dutch tariff, 0.80 ± 0.20 with U.K. tariff). All new models yielded predicted utilities drawing close to observed utilities; differences were not statistically significant. The existing algorithms resulted in an ICER difference of €10,140 less and €1765 more compared to the observed EQ-5D-3L based ICER (€168,048). The preferred newly developed algorithm was €5094 higher than the observed EQ-5D-3L based ICER. Disparity was explained by minimal diffences in incremental QALYs between models. CONCLUSION: Available mapping algorithms sufficiently accurately predict utilities. With the commonly used statistical methods, we did not succeed in developping an improved mapping algorithm. Importantly, cost-effectiveness outcomes in this study were comparable to the original model outcomes between different mapping algorithms. Therefore, mapping can be an adequate solution for cost-effectiveness studies using either a previously designed and validated algorithm or an algorithm developed in this study. BioMed Central 2020-07-20 /pmc/articles/PMC7370458/ /pubmed/32690011 http://dx.doi.org/10.1186/s12955-020-01481-2 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Franken, Mira D.
de Hond, Anne
Degeling, Koen
Punt, Cornelis J. A.
Koopman, Miriam
Uyl-de Groot, Carin A.
Versteegh, Matthijs M.
van Oijen, Martijn G. H.
Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model
title Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model
title_full Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model
title_fullStr Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model
title_full_unstemmed Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model
title_short Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model
title_sort evaluation of the performance of algorithms mapping eortc qlq-c30 onto the eq-5d index in a metastatic colorectal cancer cost-effectiveness model
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370458/
https://www.ncbi.nlm.nih.gov/pubmed/32690011
http://dx.doi.org/10.1186/s12955-020-01481-2
work_keys_str_mv AT frankenmirad evaluationoftheperformanceofalgorithmsmappingeortcqlqc30ontotheeq5dindexinametastaticcolorectalcancercosteffectivenessmodel
AT dehondanne evaluationoftheperformanceofalgorithmsmappingeortcqlqc30ontotheeq5dindexinametastaticcolorectalcancercosteffectivenessmodel
AT degelingkoen evaluationoftheperformanceofalgorithmsmappingeortcqlqc30ontotheeq5dindexinametastaticcolorectalcancercosteffectivenessmodel
AT puntcornelisja evaluationoftheperformanceofalgorithmsmappingeortcqlqc30ontotheeq5dindexinametastaticcolorectalcancercosteffectivenessmodel
AT koopmanmiriam evaluationoftheperformanceofalgorithmsmappingeortcqlqc30ontotheeq5dindexinametastaticcolorectalcancercosteffectivenessmodel
AT uyldegrootcarina evaluationoftheperformanceofalgorithmsmappingeortcqlqc30ontotheeq5dindexinametastaticcolorectalcancercosteffectivenessmodel
AT versteeghmatthijsm evaluationoftheperformanceofalgorithmsmappingeortcqlqc30ontotheeq5dindexinametastaticcolorectalcancercosteffectivenessmodel
AT vanoijenmartijngh evaluationoftheperformanceofalgorithmsmappingeortcqlqc30ontotheeq5dindexinametastaticcolorectalcancercosteffectivenessmodel